Plair raises CHF 1 million to expand real-time microbial detection
27.03.2026
Geneva-based Plair is taking a step forward in cleanroom monitoring with its flagship solution, RAPID-C+, a real-time particle counter for viable and total microorganisms in pharmaceutical environments. The company has raised CHF 1 million from bioMérieux, a global leader in in vitro diagnostics, to accelerate the global rollout of its technology.
 |
 |
RAPID-C+ is already commercially available, and Plair, a Venture Kick alumnus, has raised CHF 1 million from bioMérieux to accelerate its global rollout. The system combines continuous sampling on standard agar media with instant particle counting, enabling faster microbial identification and more informed decision-making in cleanrooms.
Plair will continue working with its global network of partners and distributors to bring RAPID-C+ to pharmaceutical manufacturers worldwide. The investment reflects bioMérieux’s strategy to strengthen its Pharma Quality Control offerings and support innovation in environmental monitoring, drawing on more than 60 years of scientific expertise and a partner-focused approach.
Plair will continue working with its global network of partners and distributors to bring RAPID-C+ to pharmaceutical manufacturers worldwide. The investment reflects bioMérieux’s strategy to strengthen its Pharma Quality Control offerings and support innovation in environmental monitoring, drawing on more than 60 years of scientific expertise and a partner-focused approach.